Lymphoma na iya tashi a wurare daban-daban a cikin jiki, kuma wasu shafuka suna da rassa fiye da sauran. Ga wasu cututtuka, wasu lokuta babu wani irin abu wanda ya dace. A cikin wadannan lokuta, likitoci sunyi mafi kyau don samun magani wanda zai sami mafi girma gagarumar tasiri tare da ƙananan ƙwayar cuta. Yawan shekarunku da kuma jihohi na kiwon lafiyar na iya zama manyan dalilai a yanke shawarar abin da hanyoyin kwantar da hankali zai dace a gare ku.
Primary Primary Nervous System Lymphoma
Sashen lymphoma na tsakiya na farko (PCNSL) wani nau'in ƙwayar lymphoma da ba na Hodgkin ne mai rikitarwa. Sanarwar ta nuna cewa matalauta ne musamman ga wadanda ke cikin shekaru 60 da tsufa.
Rabin dukkan lokuta na PCNSL yana faruwa a cikin wannan rukuni.
Kodayake yana da wuya, PCNSL ta ci gaba a cikin shekaru 30 da suka gabata. Nazarin likitoci 579 wadanda aka gano da PCNSL a cikin shekarun 1990s a Amurka sun nuna cewa rayuwa ta tsakiya ita ce kawai watanni 7. A wannan lokacin, dukkanin kwakwalwa na kwakwalwar kwakwalwa shine mafi yawan maganin da ake yi a wannan rukuni, a kashi 46 cikin 100.
Kodayake mutane masu tsufa za su iya jure wa tsarin kula da cutar kwarewa don PCNSL, sun kasance suna da matsala mafi kyau idan aka kwatanta da ƙananan marasa lafiya. Maganin mutane sun fi fama da mummunan cututtuka, musamman magungunan cutar da ke cikin kwakwalwar rediyo.
Ana fama da marasa lafiya tare da lymphoma na CNS na farko a wasu hanyoyi guda biyu: lokacin haɓaka, nufin ɗaukar gafara, da kuma lokacin ƙarfafawa, da aka ba da zarar an sami remission.
Mafi yawan maganin da aka saba da shi shi ne Trexall (methotrexate) wanda ya dace da maganin cutar shan-jijiyoci wanda ya biyo bayan rediyo na kwakwalwa gaba daya, amma yawancin marasa lafiya ya dawo daga lymphoma ko kuma ya kara yawan haɗari ga tsarin mai juyayi.
Jiyya Patterns
Bisa wannan kalubalen, Dokta Benjamin Kasenda da abokan aiki sunyi nazari don nazarin ilimin cututtuka da ake amfani dasu ga wannan cuta a cikin mutane fiye da 60.
Musamman, sun so su san ko wane hanyoyin likita masu amfani da kwayar cutar da aka yi amfani da su a matsayin farko na farko a cikin marasa lafiya tare da sabuwar PCNSL da aka gano.
Sun sami binciken 20 da aka wallafa, ciki har da bayanin daga marasa lafiya 783 da suka hadu da ka'idodin binciken su, wanda aka saba da su tare da PCNSL, shekarun da suka wuce shekaru 60 da kuma tsarin marasa lafiya. Gaba ɗaya, sun samo maganin farko na mutanen da ke cikin wannan rukuni sun bambanta, kuma babu wata cikakkiyar magani ga marasa lafiya marasa lafiya da PCNSL.
Binciken Bincike
- Masu bincike sun gano cewa, a cikin shekaru goma da suka gabata, haɓakawa a wannan rukuni na zamani ya inganta.
- Kwayoyin cutar da suka shafi mahimmanci kashi-kashi sun hada da sakamakon mafi kyau.
- Matsayi mai zurfi tare da akalla biyu magungunan kwayoyi - m magani - idan aka kwatanta da ƙananan kashi-kashi da magungunan chemotherapy ba su da dangantaka da ingantaccen amsa ko rayuwa
- A cikin mutanen da suka karbi kashi-kashi-kashi na tushen chemotherapy, dukan kwakwalwar rediyon rediyo ya hade da inganta rayuwar, amma kuma tare da haɗarin hadarin sakamako na kwayoyin halitta.
- Methotrexate ita ce mafi yawan maganin ƙwayar magani a cikin maganin PCNSL. Ƙananan marasa lafiya yanzu ana bi da su tare da cikakkiyar farfadowa ta kwakwalwa, kawai.
Layin Ƙasa
Wannan binciken ya sake duba abin da ya faru a baya. Ya kasance nazari na nazari, kuma saboda haka yana da wasu mahimmancin iyakancewa. Duk da haka, ƙarin bayanai masu mahimmanci daga PCNSL yiwuwar gwaji a cikin tsofaffi ba su samuwa. Ga abin da wannan rukuni ya gama:
- Ya kamata a miƙa magungunan ƙananan matakai-hanya mai mahimmanci har ma da marasa lafiya, idan ya yiwu.
- Yin maganin farko tare da haɗuwa da ƙididdigar mataki tare da magungunan maganganu, procarbazine ko temozolomide, alal misali-sun kasance kamar alamar wajabi ne kuma ya cancanci a kara nazarin.
- Kwararren rediyo na kwakwalwa na iya inganta sakamako, amma yana haɗuwa da haɗarin haɗari ga sakamako mai illa.
A ƙarshe, Kasenda da abokan aiki sun nuna muhimmancin gwajin da aka tsara don marasa lafiya na PCNSL.
> Sources:
Ferreri AJM, Cwynarski K, Pulczynski E, et al. Chemoimmunotherapy tare da Methotrexate, Cytarabine, Thiotepa, da kuma Rituximab (MATRix Regimen) a cikin marasa lafiya tare da Likita na CNS Lymphoma: Sakamako na Farko na Halitta na Ƙungiyar Nazarin Kwalejin Samphoma na Kwalejin Lymphoma-32 (IELSG32). Lancet Hematology. 2016; 5; e217-e227.
Kasenda B, Ferreri AJM, Marturano E, et al. Lafiya na farko da sakamakon waɗanda ke da tsofaffi marasa lafiya tare da tsarin kulawa na tsakiya na tsakiya na Lymphoma (PCNSL) - Binciken Tsaro da Mutum na Matu-Analysis na Mutum. Ann Oncol . 2015. [Epub gaba na buga].
Roth P, Hoang-Xuan K. Ƙalubalen da ke Kula da marasa lafiyar marasa lafiya tare da tsarin kula da yara na tsakiya na tsakiya na Lymphoma. Curr Opin Neurol. 2014; 27: 697-701.
Panageas KS, Elkin EB, Ben-Porat L, et al. Alamu na Jiyya a tsofaffi da manya tare da na farko na tsakiya na juyayi System Lymphoma. Kankara 2007; 110: 1338-1344.